Latest / Clinical Capsules - Actionable Medication Pearls in Minutes
Semaglutide Becomes the First ORAL GLP-1 Approved for Weight Loss
A new oral option is changing the GLP-1 landscape for weight loss, along with raising questions about efficacy, dosing, and when switching products makes sense.
In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD discusses how semaglutide became the first FDA-approved oral GLP-1 agonist for obesity. She breaks down how it works, how it compares to injectable options, and dosing considerations for patients. Vickie also walks through key counseling points around administration, side effects, cost, and product mix-ups, and offers practical guidance on…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.